×

Subscribe Today

Get our free articles delivered directly to your email!

Continue reading

Insider Transactions by ABERNETHY MATT

Symbol CompanyOwnerRelationshipDateTransactionCost# SharesValue ($)Total SharesFiling
NBIXNEUROCRINE BIOSCIENCES INCABERNETHY MATTChief Financial OfficerMay 14, 2024Option Exercise$73.6015,0001,104,00046,528May 16, 2024, 04:40 PM
NBIXNEUROCRINE BIOSCIENCES INCABERNETHY MATTChief Financial OfficerMay 14, 2024Sale$135.6615,0002,034,82731,528May 16, 2024, 04:40 PM
NBIXNEUROCRINE BIOSCIENCES INCABERNETHY MATTChief Financial OfficerMay 15, 2024Option Exercise$73.6015,0001,104,00046,528May 16, 2024, 04:40 PM
NBIXNEUROCRINE BIOSCIENCES INCABERNETHY MATTChief Financial OfficerMay 15, 2024Sale$140.2415,0002,103,60931,528May 16, 2024, 04:40 PM
NBIXNEUROCRINE BIOSCIENCES INCABERNETHY MATTChief Financial OfficerFeb 13, 2024Sale$132.851,352179,61231,528Feb 15, 2024, 05:27 PM
NBIXNEUROCRINE BIOSCIENCES INCABERNETHY MATTChief Financial OfficerFeb 08, 2024Sale$134.21980131,52930,314Feb 08, 2024, 07:12 PM
NBIXNEUROCRINE BIOSCIENCES INCABERNETHY MATTChief Financial OfficerFeb 06, 2024Sale$142.191,280182,00029,434Feb 08, 2024, 07:12 PM
NBIXNEUROCRINE BIOSCIENCES INCABERNETHY MATTChief Financial OfficerJan 31, 2024Sale$140.721,283180,53928,284Feb 02, 2024, 07:00 PM
NBIXNEUROCRINE BIOSCIENCES INCABERNETHY MATTChief Financial OfficerAug 21, 2023Sale$107.392,132228,95827,131Aug 23, 2023, 07:58 PM
NBIXNEUROCRINE BIOSCIENCES INCABERNETHY MATTChief Financial OfficerFeb 07, 2023Sale$102.4026,3282,696,10735,824Feb 08, 2023, 07:16 PM
NBIXNEUROCRINE BIOSCIENCES INCABERNETHY MATTChief Financial OfficerFeb 08, 2023Sale$104.19980102,11025,213Feb 08, 2023, 07:16 PM
NBIXNEUROCRINE BIOSCIENCES INCABERNETHY MATTChief Financial OfficerFeb 06, 2023Sale$105.671,280135,25322,507Feb 08, 2023, 07:16 PM
NBIXNEUROCRINE BIOSCIENCES INCABERNETHY MATTChief Financial OfficerJan 31, 2023Sale$109.981,283141,10821,357Feb 02, 2023, 04:53 PM
NBIXNEUROCRINE BIOSCIENCES INCABERNETHY MATTChief Financial OfficerFeb 07, 2022Sale$80.793,310267,42819,325Feb 09, 2022, 06:51 PM
NBIXNEUROCRINE BIOSCIENCES INCABERNETHY MATTChief Financial OfficerFeb 08, 2022Sale$79.6598078,05820,204Feb 09, 2022, 06:51 PM
NBIXNEUROCRINE BIOSCIENCES INCABERNETHY MATTChief Financial OfficerDec 01, 2021Sale$82.591,645135,85216,349Dec 03, 2021, 05:02 PM
NBIXNEUROCRINE BIOSCIENCES INCABERNETHY MATTChief Financial OfficerFeb 08, 2021Sale$116.822,910339,94214,869Feb 09, 2021, 09:30 PM
NBIXNEUROCRINE BIOSCIENCES INCABERNETHY MATTChief Financial OfficerDec 01, 2020Sale$94.661,645155,72111,494Dec 02, 2020, 04:12 PM
NBIXNEUROCRINE BIOSCIENCES INCABERNETHY MATTChief Financial OfficerNov 12, 2020Sale$90.742,257204,81010,014Nov 16, 2020, 06:02 PM
NBIXNEUROCRINE BIOSCIENCES INCABERNETHY MATTChief Financial OfficerAug 05, 2020Sale$118.902,257268,3557,983Aug 07, 2020, 06:22 PM
NBIXNEUROCRINE BIOSCIENCES INCABERNETHY MATTChief Financial OfficerMay 07, 2020Option Exercise$73.6015,0001,104,00020,953May 11, 2020, 08:17 PM
NBIXNEUROCRINE BIOSCIENCES INCABERNETHY MATTChief Financial OfficerMay 07, 2020Sale$110.2115,0001,653,1355,953May 11, 2020, 08:17 PM
NBIXNEUROCRINE BIOSCIENCES INCABERNETHY MATTChief Financial OfficerApr 28, 2020Sale$102.491,741178,4355,953Apr 30, 2020, 04:25 PM
NBIXNEUROCRINE BIOSCIENCES INCABERNETHY MATTChief Financial OfficerApr 24, 2020Sale$99.521,934192,4677,694Apr 28, 2020, 08:32 PM
NBIXNEUROCRINE BIOSCIENCES INCABERNETHY MATTChief Financial OfficerFeb 07, 2020Sale$103.352,030209,8075,701Feb 11, 2020, 07:06 PM
NBIXNEUROCRINE BIOSCIENCES INCABERNETHY MATTChief Financial OfficerDec 02, 2019Sale$116.331,645191,3603,876Dec 04, 2019, 06:06 PM
NBIXNEUROCRINE BIOSCIENCES INCABERNETHY MATTChief Financial OfficerDec 03, 2018Sale$90.001,178106,0201,947Dec 06, 2018, 05:54 PM